We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Sick-making drugs

29 April 2004 By Hugo Dixon

Not just Sanofi and Aventis investors whose shares have slid since the agreed deal was announced. Novartis too must be feeling sick. The more Aventis tumbles, the more it must feel it let a deal slip through its fingers.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)